DuPont Pioneer Announces Roll-Out of Global Genotypic Data Management System to Accelerate Agriculture Solutions for Farmers
News Sep 22, 2013
DuPont Pioneer and UNIConnect have announced the global roll-out of a lab information management system to help Pioneer accelerate the development of new plant products with higher yields and stronger resistance to pests and diseases.
“Incorporating technology provided by UNIConnect offers flexibility and reliability in our lab information management system, while also supporting our critical global information management implementation,” said John Arbuckle, DuPont Pioneer senior director, Global Marker and Research Information Technologies. “This is helping to sustain our leading position in generating and applying genetic information for plant development scientists who are improving key crops around the world. Integrating this information technology platform into our existing proprietary solutions and processes expands our global production genotyping system capability.”
Now live in eight locations located across four continents, individual global marker technology sites have autonomously-functioning Laboratory Information Management System (LIMS) operations. Arbuckle noted that the project is capturing millions of data points each day and already delivering enhanced performance reliability, traceability and reliability of results. Running in parallel, the new system operates as a federated network – meaning sites can operate independently or as a global network.
“We are proud to provide information technology to a world leader in plant genomics and crop science,” noted William S. Harten, UNIConnect founder and chief executive officer. “Our technology began in the realm of plant genomics R&D, and we are gratified to witness the increasing adoption of UNIFlow by great agricultural businesses like DuPont Pioneer.”
LifeArc and Milner Therapeutics Institute Announce a New Partnership in AI for Target DiscoveryNews
LifeArc®, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, today announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.READ MORE
Drug-like Compounds Reverse Chemotherapy Failure for 3 Aggressive CancersNews
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers -- ovarian, prostate and breast.READ MORE
Algorithm Unearths Over 1000 Antibiotic Proteins in a Few HoursNews
The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.READ MORE